These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 11117652

  • 1. Zaleplon: a pyrazolopyrimidine sedative-hypnotic agent for the treatment of insomnia.
    Weitzel KW, Wickman JM, Augustin SG, Strom JG.
    Clin Ther; 2000 Nov; 22(11):1254-67. PubMed ID: 11117652
    [Abstract] [Full Text] [Related]

  • 2. Zaleplon: a review of its use in the treatment of insomnia.
    Dooley M, Plosker GL.
    Drugs; 2000 Aug; 60(2):413-45. PubMed ID: 10983740
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia. The Zaleplon Clinical Investigator Study Group.
    Hedner J, Yaeche R, Emilien G, Farr I, Salinas E.
    Int J Geriatr Psychiatry; 2000 Aug; 15(8):704-12. PubMed ID: 10960882
    [Abstract] [Full Text] [Related]

  • 6. Safety of zaleplon in the treatment of insomnia.
    Israel AG, Kramer JA.
    Ann Pharmacother; 2002 May; 36(5):852-9. PubMed ID: 11978165
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of zaleplon at peak plasma levels.
    Mangano RM.
    Int J Clin Pract Suppl; 2001 Jan; (116):9-13. PubMed ID: 11219331
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Pharma-clinics. Drug of the month. Zaleplon (Sonata)].
    Ansseau M.
    Rev Med Liege; 1999 Aug; 54(8):705-6. PubMed ID: 10548901
    [Abstract] [Full Text] [Related]

  • 11. Benefit-risk assessment of zaleplon in the treatment of insomnia.
    Barbera J, Shapiro C.
    Drug Saf; 2005 Aug; 28(4):301-18. PubMed ID: 15783240
    [Abstract] [Full Text] [Related]

  • 12. Management of insomnia--the role of zaleplon.
    Richardson GS, Roth T, Kramer JA.
    MedGenMed; 2002 Mar 14; 4(1):9. PubMed ID: 11965211
    [Abstract] [Full Text] [Related]

  • 13. Lack of residual sedation following middle-of-the-night zaleplon administration in sleep maintenance insomnia.
    Walsh JK, Pollak CP, Scharf MB, Schweitzer PK, Vogel GW.
    Clin Neuropharmacol; 2000 Mar 14; 23(1):17-21. PubMed ID: 10682226
    [Abstract] [Full Text] [Related]

  • 14. Zaleplon improves sleep without producing rebound effects in outpatients with insomnia. Zaleplon Clinical Study Group.
    Fry J, Scharf M, Mangano R, Fujimori M.
    Int Clin Psychopharmacol; 2000 May 14; 15(3):141-52. PubMed ID: 10870872
    [Abstract] [Full Text] [Related]

  • 15. Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia.
    Najib J.
    Clin Ther; 2006 Apr 14; 28(4):491-516. PubMed ID: 16750462
    [Abstract] [Full Text] [Related]

  • 16. Implications of hypnotic flexibility on patterns of clinical use.
    Lader MH.
    Int J Clin Pract Suppl; 2001 Jan 14; (116):14-9. PubMed ID: 11219327
    [Abstract] [Full Text] [Related]

  • 17. Zaleplon for insomnia.
    Med Lett Drugs Ther; 1999 Oct 08; 41(1063):93-4. PubMed ID: 10535052
    [No Abstract] [Full Text] [Related]

  • 18. Sleep and residual sedation after administration of zaleplon, zolpidem, and placebo during experimental middle-of-the-night awakening.
    Zammit GK, Corser B, Doghramji K, Fry JM, James S, Krystal A, Mangano RM.
    J Clin Sleep Med; 2006 Oct 15; 2(4):417-23. PubMed ID: 17557470
    [Abstract] [Full Text] [Related]

  • 19. Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia.
    Holm KJ, Goa KL.
    Drugs; 2000 Apr 15; 59(4):865-89. PubMed ID: 10804040
    [Abstract] [Full Text] [Related]

  • 20. New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon.
    Terzano MG, Rossi M, Palomba V, Smerieri A, Parrino L.
    Drug Saf; 2003 Apr 15; 26(4):261-82. PubMed ID: 12608888
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.